Literature DB >> 311166

beta-Ray treatment of malignant epibulbar melanoma.

P K Lommatzsch.   

Abstract

Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 311166     DOI: 10.1007/bf00407844

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  13 in total

1.  Radiotherapy of malignant melanomata of the eye.

Authors:  M LEDERMAN
Journal:  Br J Radiol       Date:  1961-01       Impact factor: 3.039

2.  An evaluation of the clinical use of a strontium 90 beta-ray applicator with a review of the underlying principles.

Authors:  H L FRIEDELL; C I THOMAS; J S KROHMER
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1954-01

3.  Benign pigmented tumors, arising in acquired conjunctival melanosis.

Authors:  F J Elsas; W R Green; S J Ryan
Journal:  Am J Ophthalmol       Date:  1974-08       Impact factor: 5.258

4.  [Conservative theapy of malignant melanoma of the conjunctiva originating from a melanotic preblastomatosis Dubreuilh].

Authors:  F Schlieter
Journal:  Klin Monbl Augenheilkd       Date:  1972-10       Impact factor: 0.700

5.  Radioactive scleral shells in the treatment of conjunctival tumors.

Authors:  D Miller; J M Carroll; A Holmberg; M D Schulz; R Wipfelder
Journal:  Am J Ophthalmol       Date:  1970-11       Impact factor: 5.258

6.  A clinicopathologic study of prognostic factors in cutaneous malignant melanoma.

Authors:  E G Elias; M S Didolkar; I P Goel; J F Formeister; L A Valenzuela; J L Pickren; R H Moore
Journal:  Surg Gynecol Obstet       Date:  1977-03

7.  Precancerous and cancerous melanosis.

Authors:  A B Reese
Journal:  Am J Ophthalmol       Date:  1966-05       Impact factor: 5.258

8.  Melanocytic lesions of the eyelid skin.

Authors:  M A Naidoff; V B Bernardino; W H Clark
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

9.  Malignant melanomas of the conjunctiva.

Authors:  V B Bernardino; M A Naidoff; W H Clark
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

Review 10.  Beta-ray treatment of malignant epithelial tumors of the conjunctiva.

Authors:  P Lommatzsch
Journal:  Am J Ophthalmol       Date:  1976-02       Impact factor: 5.258

View more
  6 in total

1.  Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.

Authors:  Henrike Wuestemeyer; Wolfgang Sauerwein; Daniel Meller; Pierre Chauvel; Andreas Schueler; Klaus-Peter Steuhl; Norbert Bornfeld; Gerasimos Anastassiou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

2.  Topical chemotherapy for conjunctival melanoma.

Authors:  P T Finger; M S Milner; S A McCormick
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

3.  Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

Authors:  P T Finger; G Czechonska; S Liarikos
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

4.  Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.

Authors:  P K Lommatzsch
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

5.  Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.

Authors:  P K Lommatzsch; R E Lommatzsch; I Kirsch; P Fuhrmann
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

6.  The use of strontium-90 Beta radiotherapy as adjuvant treatment for conjunctival melanoma.

Authors:  Victoria M L Cohen; Vasilios P Papastefanou; S Liu; Ian Stoker; John L Hungerford
Journal:  J Oncol       Date:  2013-01-31       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.